Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Meet Our
Team

Michael Hartman

Chief Operating Officer

Psilocybin Nasal Spray Creator
Formerly Product Development

Michael Hartman is an accomplished pharmaceutical product developer inventor, scientist and self-styled disruptive force in the pharmaceutical industry. He served as Senior Scientist at Novartis where he developed a novel triple drug combination dry powder inhaler for COPD and invented a robust formulation platform technology. Hartman’s work at Novartis earned the Global Innovation of the Year Award for the iPulmoSpheres invention.

Mr. Hartman holds five patents in the fields of pharmaceutical aerosol formulation, including the AeroSphere patent obtained as Employee #1 at Pearl Therapeutics. He is a published expert on respiratory drug delivery, and an expert on formulations for both pressurized metered dose inhalers (pMDI) and dry powder inhalers (DPI).

He left Big Pharma to lead a revolution in the cannabis space with the invention of his metered-dose full-spectrum, whole plant CBD/THC inhaler and later was a co-inventor of Silo’s metered dosing psilocybin nasal spray.

Mr. Hartman received his BS in Chemistry from University of California. In true Silicon Valley fashion, he is a drop out of the Physical Chemistry PhD program at University of Arizona, one of the top chemistry programs in the country.